Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults.

Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton RB, Pascual J, Wang SJ; Task Force of the International Headache Society Clinical Trials Subcommittee.

Cephalalgia. 2008 May;28(5):484-95. doi: 10.1111/j.1468-2982.2008.01555.x. Epub 2008 Feb 20. Erratum in: Cephalalgia. 2008 Jun;28(6):679.

PMID:
18294250
2.

Are the current IHS guidelines for migraine drug trials being followed?

Hougaard A, Tfelt-Hansen P.

J Headache Pain. 2010 Dec;11(6):457-68. doi: 10.1007/s10194-010-0257-5. Epub 2010 Oct 8. Review.

3.
4.

Prophylactic treatment of migraine in children. Part 2. A systematic review of pharmacological trials.

Damen L, Bruijn J, Verhagen AP, Berger MY, Passchier J, Koes BW.

Cephalalgia. 2006 May;26(5):497-505. Review.

PMID:
16674757
5.

[Drug treatment of migraine in children: state of the art].

Cuvellier JC, Joriot S, Auvin S, Vallée L.

Arch Pediatr. 2004 May;11(5):449-55. Review. French.

PMID:
15135430
6.

[Controlled therapeutic trials in migraine: methodology and results].

Baron JC, Bousser MG.

Rev Neurol (Paris). 1982;138(4):279-95. Review. French.

PMID:
6753081
7.

Treatment of migraine with prophylactic drugs.

Evers S.

Expert Opin Pharmacother. 2008 Oct;9(15):2565-73. doi: 10.1517/14656566.9.15.2565 . Review.

PMID:
18803445
8.

Acute treatment of migraine in children and adolescents.

Termine C, Ferri M, Balottin U.

Funct Neurol. 2008 Apr-Jun;23(2):63-9. Review.

PMID:
18671905
9.

Migraine treatment.

Becker WJ, Gawel M, Mackie G, South V, Christie SN.

Can J Neurol Sci. 2007 Nov;34(4):S10-9. Review.

PMID:
18062466
10.

[Treatment guidelines for preventive treatment of migraine].

Treatment Guideline Subcommittee of the Taiwan Headache Society.

Acta Neurol Taiwan. 2008 Jun;17(2):132-48. Review. Chinese.

PMID:
18686655
11.

Migraine treatment throughout the lifecycle.

Landy SH, Lobo BL.

Expert Rev Neurother. 2005 May;5(3):343-53. Review.

PMID:
15938667
12.

Clinical considerations on chronic migraine, pharmacoresistance and refractoriness.

Bussone G.

Neurol Sci. 2010 Jun;31 Suppl 1:S83-5. doi: 10.1007/s10072-010-0294-5. Review.

PMID:
20464591
13.

What do patients want from their acute migraine therapy?

Lantéri-Minet M.

Eur Neurol. 2005;53 Suppl 1:3-9. Epub 2005 May 3. Review.

PMID:
15920331
14.

[Therapeutic guidelines for headache].

Nappi G, Cavallini A.

Ital J Neurol Sci. 1995 Nov;16(8 Suppl):29-34. Review. Italian.

PMID:
8751186
15.

The diagnosis and treatment of migraine: a clinician's view.

Edmeads J.

Eur Neurol. 1994;34 Suppl 2:2-5. Review.

PMID:
7835379
16.

Prophylactic treatment of migraine in children. Part 1. A systematic review of non-pharmacological trials.

Damen L, Bruijn J, Koes BW, Berger MY, Passchier J, Verhagen AP.

Cephalalgia. 2006 Apr;26(4):373-83. Review.

PMID:
16556238
17.

Current therapies in childhood and adolescent migraine.

Pakalnis A.

J Child Neurol. 2007 Nov;22(11):1288-92. Review.

PMID:
18006958
18.

Triptans vs other drugs for acute migraine. Are there differences in efficacy? A comment.

Tfelt-Hansen P.

Headache. 2008 Apr;48(4):601-5. doi: 10.1111/j.1526-4610.2008.01064.x. Review.

PMID:
18377382
19.

Early treatment of migraine attacks with triptans: a strategy to enhance outcomes and patient satisfaction?

D'Amico D, Moschiano F, Bussone G.

Expert Rev Neurother. 2006 Jul;6(7):1087-97. Review.

PMID:
16831121
20.

Evidence based migraine prophylactic drug therapy.

Becker WJ.

Can J Neurol Sci. 1999 Nov;26 Suppl 3:S27-32. Review.

PMID:
10563230

Supplemental Content

Support Center